Alpha Tau Medical Ltd. DRTS
13.56 USD +0.73 (+5.69%)
Nov 3, 2026, 3:25 PM EST
13.07 Day range 13.55
3.43 52-week range 15.79
- YTD
- +173.94%
- 1 year
- +245.92%
Analyst view
Consensus: buy
Buy
Price target (mean) 17.80 +31.3% upside
Now 13.56
- Target (low)
- 8.00
- Target (mean)
- 17.80
- Target (high)
- 30.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.14672 | -0.16 – -0.13 | -0.14 | -4.8% | 324.33K | 0.0% | 4 |
| Next quarter | -0.15177 | -0.17 – -0.13 | -0.14 | -8.4% | 617.00K | 0.0% | 4 |
| Current year | -0.95541 | -1.08 – -0.551 | -0.53 | -80.3% | 944.33K | 0.0% | 5 |
| Next year | -0.53458 | -0.60 – -0.50 | -0.95541 | +44.0% | 12.61M | +1235.6% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 11, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 22, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 16, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 4, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 28, 2026 | Barclays | Initiated | — | Overweight |
| May 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 19, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| May 12, 2026 | Ladenburg Thalmann | Maintained | Buy | Buy |
| May 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 11, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 4, 2026 | Piper Sandler | Downgrade | Overweight | Neutral |
| Feb 24, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 10, 2025 | Citigroup | Maintained | Buy | Buy |
| Nov 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 22, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 29, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 17, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jun 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |